These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25765802)

  • 21. [Haploidentical transplantation using post-transplant high-dose cyclophosphamide for adult T-cell lymphoma after mogamulizumab treatment].
    Kusakabe M; Kurita N; Nishikii H; Sato R; Yoshida C; Yokoyama Y; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Rinsho Ketsueki; 2017; 58(5):449-454. PubMed ID: 28592758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adult T-cell leukemia-lymphoma complicated by Takotsubo cardiomyopathy and HTLV-1-associated myelopathy after treatment with the anti-CCR4 antibody mogamulizumab].
    Yamanaka S; Nakayama K; Tamai H; Sakamaki M; Inokuchi K
    Rinsho Ketsueki; 2017; 58(4):309-314. PubMed ID: 28484158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis.
    Lechowicz MJ; Smith C; Ristuccia R; Dwyer K
    Int J Hematol; 2024 Jun; 119(6):736-744. PubMed ID: 38532079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma.
    Inoue Y; Fuji S; Tanosaki R; Inamoto Y; Tanaka T; Ito A; Okinaka K; Kurosawa S; Kim SW; Nakagama H; Fukuda T
    Bone Marrow Transplant; 2018 Sep; 53(9):1105-1115. PubMed ID: 29523883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
    Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Hanabuchi S; Masuda M; Ohashi T; Fukui F; Hasegawa A; Masuda T; Takaue Y; Okamura J; Kannagi M
    Cancer Res; 2004 Jan; 64(1):391-9. PubMed ID: 14729650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma.
    Winsett FT; Lewis DJ; Duvic M
    Expert Rev Hematol; 2017 Sep; 10(9):757-760. PubMed ID: 28756726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment strategy in corporating mogamulizumab and cord blood transplantation in aggressive adult T-cell leukemia-lymphoma: a case report.
    Nakata K; Fuji S; Koike M; Tada Y; Masaie H; Yoshida H; Watanabe E; Kobayashi S; Tojo A; Uchimaru K; Ishikawa J
    Blood Cell Ther; 2020 Feb; 3(1):6-10. PubMed ID: 37465376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014).
    Kawano N; Kuriyama T; Sonoda KH; Yoshida S; Yamashita K; Ochiai H; Shimoda K; Ishikawa F; Ueda A; Kikuchi I
    Intern Med; 2016; 55(11):1439-45. PubMed ID: 27250049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence of Psoriasis Vulgaris Accompanied by Treatment with C-C Chemokine Receptor Type 4 (CCR4) Antibody (Mogamulizumab) Therapies in a Patient with Adult T cell Leukemia/ Lymphoma: Insight into Autoinflammatory Diseases.
    Morichika K; Tomoyose T; Hanashiro T; Shimabukuro N; Tamaki K; Tedokon I; Nishi Y; Nakachi S; Karube KN; Fukushima T; Katoh T; Ohshima K; Masuzaki H
    Intern Med; 2016; 55(10):1345-9. PubMed ID: 27181545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphoma.
    Fujii K; Sakamoto Y; Masaki A; Murase T; Tashiro Y; Yonekura K; Utsunomiya A; Ito A; Kusumoto S; Iida S; Ueda R; Ishida T; Inagaki H
    J Pathol Clin Res; 2021 Jan; 7(1):52-60. PubMed ID: 33022137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.
    Fuji S; Shindo T
    Stem Cell Investig; 2016; 3():70. PubMed ID: 27868052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation.
    Inoue Y; Endo S; Matsuno N; Kikukawa Y; Shichijo T; Koga K; Takaki A; Iwanaga K; Nishimura N; Fuji S; Fukuda T; Nosaka K; Matsuoka M
    Bone Marrow Transplant; 2019 Feb; 54(2):338-342. PubMed ID: 30116017
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation.
    Motohashi K; Suzuki T; Kishimoto K; Numata A; Nakajima Y; Tachibana T; Ohshima R; Kuwabara H; Tanaka M; Tomita N; Ishigatsubo Y; Fujisawa S
    Int J Hematol; 2013 Aug; 98(2):258-60. PubMed ID: 23801427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult T-Cell Leukemia-Lymphoma.
    Munakata W; Tobinai K
    Cancer Treat Res; 2019; 176():145-161. PubMed ID: 30596217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of adult T-cell leukemia.
    Uozumi K
    J Clin Exp Hematop; 2010; 50(1):9-25. PubMed ID: 20505272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL].
    Tanaka Y; Kanda Y
    Rinsho Ketsueki; 2015 Jul; 56(7):815-24. PubMed ID: 26251144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.
    Sakamoto Y; Ishida T; Masaki A; Murase T; Ohtsuka E; Takeshita M; Muto R; Iwasaki H; Ito A; Kusumoto S; Nakano N; Tokunaga M; Yonekura K; Tashiro Y; Iida S; Utsunomiya A; Ueda R; Inagaki H
    Hematol Oncol; 2022 Dec; 40(5):876-884. PubMed ID: 36043457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of allogeneic hematopoietic cell transplantation in patients with adult T-cell leukemia.
    Kamiunten A; Sekine M; Kameda T; Akizuki K; Tahira Y; Shide K; Shimoda H; Kato K; Hidaka T; Kubuki Y; Shimoda K
    Hematol Oncol; 2018 Oct; 36(4):651-655. PubMed ID: 30117169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
    Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M
    Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma.
    Ureshino H; Kamachi K; Kimura S
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):326-331. PubMed ID: 30981611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.